Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial

Affiliations

• ¹ Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
• ² The George Institute for Global Health, UNSW Sydney, New South Wales, Australia.
• ³ Cardiovascular Division, Brigham & Women's Hospital and Baim Institute for Clinical Research, Boston, MA.
• ⁴ Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
• ⁵ Indiana University School of Medicine and VA Medical Center, Indianapolis, Indiana.
• ⁶ Department of Medicine, University of Chicago Medicine, Chicago, IL.
• ⁷ Nephrology Division, NYU School of Medicine and NYU Langone Medical Center, New York, NY.
• ⁸ Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
• ⁹ Division of Biostatistics, Department of Population Health Sciences, University of Utah, Salt Lake City, UT.
• ¹⁰ The George Institute for Global Health, UNSW Sydney, New South Wales, Australia; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
• ¹¹ Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
• ¹² The George Institute for Global Health, UNSW Sydney, New South Wales, Australia; Imperial College London, London, UK.
• ¹³ Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
• ¹⁴ The George Institute for Global Health, UNSW Sydney, New South Wales, Australia; Department of Renal Medicine, UCL Medical School, London, UK.
• ¹⁵ Janssen Research & Development, LLC, Raritan, NJ.
• ¹⁶ Renal Division of Peking University First Hospital, Beijing, China.
• ¹⁷ Lunenfeld-Tanenbaum Research Institute, Mt Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
• ¹⁸ The George Institute for Global Health, UNSW Sydney, New South Wales, Australia; The Royal North Shore Hospital, Sydney, Australia.
• ¹⁹ Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA. Electronic address: [email protected].